Cell Impact (Sweden) Performance
| CI Stock | 0.08 0.02 16.00% |
The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cell Impact will likely underperform. At this point, Cell Impact AB has a negative expected return of -0.7%. Please make sure to confirm Cell Impact's value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Cell Impact AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 151.9 M |
Cell |
Cell Impact Relative Risk vs. Return Landscape
If you would invest 15.00 in Cell Impact AB on December 21, 2024 and sell it today you would lose (6.60) from holding Cell Impact AB or give up 44.0% of portfolio value over 90 days. Cell Impact AB is currently producing negative expected returns and takes up 7.9227% volatility of returns over 90 trading days. Put another way, 70% of traded stocks are less volatile than Cell, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cell Impact Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cell Impact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cell Impact AB, and traders can use it to determine the average amount a Cell Impact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0879
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CI |
Estimated Market Risk
| 7.92 actual daily | 70 70% of assets are less volatile |
Expected Return
| -0.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cell Impact is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cell Impact by adding Cell Impact to a well-diversified portfolio.
Cell Impact Fundamentals Growth
Cell Stock prices reflect investors' perceptions of the future prospects and financial health of Cell Impact, and Cell Impact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cell Stock performance.
| Return On Equity | -0.41 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.22) % | |||
| Operating Margin | (1.19) % | |||
| Current Valuation | 821.62 M | |||
| Shares Outstanding | 75.83 M | |||
| Price To Book | 2.79 X | |||
| Price To Sales | 11.09 X | |||
| Revenue | 71.35 M | |||
| EBITDA | (67.85 M) | |||
| Book Value Per Share | 4.66 X | |||
| Cash Flow From Operations | (86.08 M) | |||
| Earnings Per Share | (1.41) X | |||
| Total Asset | 238.72 M | |||
About Cell Impact Performance
Assessing Cell Impact's fundamental ratios provides investors with valuable insights into Cell Impact's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cell Impact is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Cell Impact AB performance evaluation
Checking the ongoing alerts about Cell Impact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cell Impact AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cell Impact AB generated a negative expected return over the last 90 days | |
| Cell Impact AB has high historical volatility and very poor performance | |
| Cell Impact AB has some characteristics of a very speculative penny stock | |
| Cell Impact AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 71.35 M. Net Loss for the year was (79.85 M) with profit before overhead, payroll, taxes, and interest of 34.88 M. | |
| Cell Impact generates negative cash flow from operations | |
| About 17.0% of the company shares are held by company insiders |
- Analyzing Cell Impact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cell Impact's stock is overvalued or undervalued compared to its peers.
- Examining Cell Impact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cell Impact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cell Impact's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cell Impact's stock. These opinions can provide insight into Cell Impact's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cell Stock Analysis
When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.